UPDATE | June 24, 2022

Amidst large investment from parent company, Samsung Biologics seeks to ramp up biotech funding

  • MAIL

MEDIA FOCUS 

MEDIA FOCUS

Amidst Large Investment From Parent Company, Samsung Biologics Seeks to Ramp Up Biotech Funding

John Rim

President & CEO

 

During BIO 2022 in San Diego, John Rim, CEO and President of Samsung Biologics, discussed the company’s future investments as part of its roadmap for sustainable growth with Endpoints News.

 

Read more 

 

 MEDIA FOCUS

MEDIA FOCUS

Amidst Large Investment From Parent Company, Samsung Biologics Seeks to Ramp Up Biotech Funding

John Rim

President & CEO

 

During BIO 2022 in San Diego, John Rim, CEO and President of Samsung Biologics, discussed the company’s future investments as part of its roadmap for sustainable growth with Endpoints News.

 

Read more 

 

Share article

  • MAIL

Related Content

SITE MAP

close
Close

Your download is ready

Click Download.

Close

Subscribe to Our Newsletter

Please fill in your details, select one or more areas of interest, and click the subscribe button to receive our newsletter.

Subscribe to Our Newsletter
  • Interests
  • Privacy Policy to collect the email address that I have provided until I withdraw my consent. The collected information will only be used for the purpose of mailing service. If you do not wish to consent, you will not be able to receive the newsletter. Samsung Biologics respects the privacy of its subscribers.
Close

Please fill out the form
to view the full content

Please sign up to view the post..
* Required
Privacy Policy required